CASSS Couch Chats are virtual discussion gatherings that take place in a relaxed and informal setting with a content facilitator to help drive the discussion on issues currently impacting your work. Participants are encouraged to be themselves and to share their thoughts and ideas freely. The Couch Chats will build our community and foster meaningful connections while collaborating to address real-time biopharmaceutical problems. Events will be held via Zoom and may include breakout discussions depending on the topic. Organizers may limit group size to ensure discussions are effective and diverse voices are heard.
For more information, contact Anne Ornelas.
NEW Couch Chats | What's Keeping You Up at Night? | March 28, 2023 | 12:30 EST
At CASSS, we know that solving problems and thoughtful discussions occur during many of our regulatory and technical meetings. But what about throughout the remainder of the year? Introducing Couch Chats, led by Sarah Kennett, Genentech, a Member of the Roche Group. Save the date for our first virtual Couch Chat on Thursday, March 28 at 12:30 EST. Discuss with your peers "What's Keeping You Up at Night?" and collaborate to find the solutions to your problems. If you'd like to facilitate a discussion or have a topic to suggest, please take a moment to complete our survey:
Featured Speaker Bio
Executive Portfolio Director in Pharma Technical Regulatory Biologics
Genentech, a Member of the Roche Group
Sarah Kennett is an Executive Portfolio Director in Pharma Technical Regulatory Biologics at Genentech, a Member of the Roche Group, which she joined at the end of 2017. She supports teams across the product portfolio and is involved in strategic direction, governance, and policy. She was previously the Review Chief for the U.S. FDA Office of Biotechnology Products (OBP) Division of Biotechnology Review and Research I. During her 10 years in OBP, Kennett reviewed or oversaw the CMC review of a wide variety of antibody-related and other therapeutic protein products throughout their lifecycles and was involved with numerous manufacturing facility inspections. She has experience with divergent product issues, such as those related to breakthrough products, biosimilars, and compounding, and was involved with the development of internal and external guidance and strategies for a wide range of topics. Kennett joined the FDA in 2005 as a Fellow in the Office of Cellular, Tissue, and Gene Therapies and was involved in the review of cell therapy products. She obtained her Ph.D. in molecular cancer biology at Duke University and followed that with postdoctoral training in the NIH Laboratory of Molecular Carcinogenesis. She received a BS degree in molecular and cell biology (microbiology minor) from the Pennsylvania State University.
Join us for NEW Couch Chats on March 28, 2023. Registration will close Wednesday, March 27, 2024.
CASSS On Demand
Access approved content from past meetings in the NEW CASSS On Demand platform. CASSS members have access to all available presentation recordings. Visit https://ondemand.casss.org, login to your account, and select from the list of meetings to begin.
Want to revisit a keynote presentation? Missed important details that may impact your work?
Visit Papers and Presentations to access relevant presentations, summary papers, and roundtable notes.